News Focus
News Focus
icon url

Lykiri

11/04/20 5:17 PM

#326289 RE: Sojourner55 #326287

Sojourner55,

thanks!

Late-Breaking
Plenary 1A
LTBK-02 - Phase III Clinical Trial to Test the Safety and Efficacy of Autologous Tumor Lysate-Loaded Dendritic Cells in Patients with Newly Diagnosed Glioblastoma - Withdrawn per Author
Friday, November 20, 2020 11:55 AM – 12:05 PM EST
Live Abstract Speaker(s)

LINDA M. Liau, MD, PhD, MBA

University of California Los Angeles


https://www.eventscribe.com/2020/SNO/fsPopup.asp?efp=S0taQ1hBSFkxMTYzNQ&PresentationID=772799&rnd=0.6058784&mode=presinfo
icon url

Dr Bala

11/04/20 5:21 PM

#326290 RE: Sojourner55 #326287

The poster presentation can include many more slides that contain data.
icon url

notbrad

11/04/20 5:22 PM

#326291 RE: Sojourner55 #326287

Cool! No more embargo:)
icon url

skitahoe

11/04/20 5:27 PM

#326295 RE: Sojourner55 #326287

I'm sorry to hear that it won't be presented at SNO, but if essentially the same information was to be presented weeks earlier, I think it's understandable. We should have TLD by the morning of the 9th at the very latest, and see the information that's being presented shortly thereafter.

While SITC is a Poster Presentation, frankly more can be presented there than in a 10 minute plenary presentation.

Gary
icon url

Basin Street Blues

11/04/20 5:30 PM

#326296 RE: Sojourner55 #326287

Sojourner - am i missing something ? why is this good. ?
icon url

improving

11/04/20 6:19 PM

#326319 RE: Sojourner55 #326287

Sojo, where are you seeing that all three will be doing the presentation?
Thanks.


I think TLD is Friday November 6 pre-market and details at the Galbraith Lecture followed by SITC Monday and presentation by the Three on Wednesday
icon url

VuBru

11/04/20 6:55 PM

#326344 RE: Sojourner55 #326287

Soj - I think that makes perfect sense. SNO (and all major conferences) has a rule that all talks must address new information not previously presented publicly. If NWBO for whatever reason really wants to have PR hit in a very specific timeline, and they expect to announce TLD by the time of the SITC talk next week (and discuss TLD at SITC), they would be obligated to withdraw the SNO talk. The company may simply not want to waste two weeks of PR buzz simply to meet the SNO requirements, and honestly, as an all online conference, it probably makes little difference where the results are discussed in terms of impact it will have. The only other possibility is that they know that TLD will NOT be ready by the Nov. 20 SNO date, and Liau will be talking about other things at SITC (contrary to what the title implies). Obviously, this is an extremely far fetched scenario, so TLD by Monday appears almost assured.
icon url

Smokey21

11/04/20 7:25 PM

#326368 RE: Sojourner55 #326287

I agree that SITC is probably where we will get a comprehensive readout on the trial. It gives a broader audience than just neuro oncologists. It also gives them 30 minutes instead of 10. I'm thinking they were hoping to be ready for this, but booked to SNO timeslot as a backup. Plus, this allows them to get the results out there a couple of weeks earlier with warrants locked up.
icon url

bas2020

11/04/20 10:55 PM

#326442 RE: Sojourner55 #326287

SNO Late-breaking presentation by Dr Liau is WITHDRAWN

https://www.eventscribe.com/2020/SNO/speakers.asp?pfp=Speakers


I think TLD is Friday November 6 pre-market and details at the Galbraith Lecture followed by SITC Monday and presentation by the Three on Wednesday.

Last day to buy tomorrow IMO.


Interesting! Should this be true, then certainly a price runup tomorrow.

We'll see...